REPLIMUNE GROUP, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
REPLIMUNE GROUP, INC. (REPL) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $97.00 million for the 12-month period ending 2025-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Notes › Equity
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2026-06-29
- REPLIMUNE GROUP, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2024-12-31 was $48.50M.
- REPLIMUNE GROUP, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2024-06-30 was $48.50M.
- REPLIMUNE GROUP, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2022-12-31 was $92.78M.
- REPLIMUNE GROUP, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2025 was $97.00M.
- REPLIMUNE GROUP, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2023 was $92.78M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|---|
| 2025-03-31 | $97.00M 10-K · filed 2026-06-29 | |
| 2024-12-31 | $48.50M 10-Q · filed 2026-02-03 | |
| 2024-06-30 | $48.50M 10-Q · filed 2026-02-03 | |
| 2023-03-31 | $92.78M 10-K · filed 2024-05-16 | |
| 2022-12-31 | $92.78M 10-Q · filed 2023-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |